XML 51 R37.htm IDEA: XBRL DOCUMENT v2.4.1.9
RESTRUCTURING, INTEGRATION AND OTHER CHARGES (Tables)
 12 Months Ended
Dec. 31, 2014
Restructuring and Related Activities [Abstract]  
Schedule of major components of Medicis acquisition-related costs incurred
The following table summarizes the major components of the restructuring costs incurred in connection with the B&L Acquisition since the acquisition date through December 31, 2014:
 
 
Employee Termination Costs
 
IPR&D
Termination
Costs
 
Contract
Termination,
Facility Closure
and Other Costs
 
 
 
Severance and
Related Benefits
 
Share-Based
Compensation(1)
 
 
 
Total
Balance, January 1, 2013
 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

Costs incurred and/or charged to expense
 
155.7

 
52.8

 
—

 
25.6

 
234.1

Cash payments
 
(77.8
)
 
(52.8
)
 
—

 
(7.8
)
 
(138.4
)
Non-cash adjustments
 
11.4

 
—

 
—

 
(6.8
)
 
4.6

Balance, December 31, 2013
 
$
89.3

 
$
—

 
$
—

 
$
11.0

 
$
100.3

Costs incurred and charged to expense
 
46.0

 
—

 
—

 
23.7

 
69.7

Cash payments
 
(110.7
)
 
—

 
—

 
(24.9
)
 
(135.6
)
Non-cash adjustments
 
(5.7
)
 
—

 
—

 
(5.4
)
 
(11.1
)
Balance, December 31, 2014
 
$
18.9

 
$
—

 
$
—

 
$
4.4

 
$
23.3

___________________________________
(1)
Relates to B&L’s previously cancelled performance-based options and the acceleration of unvested stock options for B&L employees as a result of the B&L Acquisition. These charges were reclassified to Other (income) expense to conform to the current year presentation.
Schedule of major components of costs incurred and a reconciliation of the liability balance
The following table summarizes the major components of the $109.2 million of restructuring costs incurred in connection with the Medicis acquisition since the acquisition date through December 31, 2014:
 
 
Employee Termination Costs
 
IPR&D
Termination
Costs
 
Contract
Termination,
Facility Closure
and Other Costs
 
 
 
Severance and
Related Benefits
 
Share-Based
Compensation(1)
 
 
 
Total
Balance, January 1, 2012
 
$
—

 
$
—

 
$
—

 
$
—

 
$
—

Costs incurred and/or charged to expense
 
85.3

 
77.3

 
—

 
0.4

 
163.0

Cash payments
 
(78.0
)
 
(77.3
)
 
—

 
—

 
(155.3
)
Non-cash adjustments
 
4.1

 
—

 
—

 
(0.2
)
 
3.9

Balance, December 31, 2012
 
11.4

 
—

 
—

 
0.2

 
11.6

Costs incurred and/or charged to expense
 
20.0

 
—

 
—

 
3.5

 
23.5

Cash payments
 
(31.4
)
 
—

 
—

 
(3.6
)
 
(35.0
)
Non-cash adjustments
 
0.3

 
—

 
—

 
(0.1
)
 
0.2

Balance, December 31, 2013(2)
 
$
0.3

 
$
—

 
$
—

 
$
—

 
$
0.3

____________________________________
(1)
Relates to the acceleration of unvested stock options, restricted stock awards, and share appreciation rights for Medicis employees that was triggered by the change in control. These charges were reclassified to Other (income) expense to conform to the current year presentation.

(2)
The Company has not recognized any restructuring charges, and made a payment of $0.1 million, in the year ended December 31, 2014 with respect to the Medicis acquisition-related initiatives.